StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
61
This month
2
This year
6
Publishing Date
2024 - 04 - 19
1
2024 - 04 - 01
1
2024 - 03 - 27
1
2024 - 03 - 18
1
2024 - 02 - 06
1
2024 - 01 - 08
1
2023 - 10 - 02
1
2023 - 09 - 25
1
2023 - 09 - 20
1
2023 - 09 - 15
2
2023 - 07 - 27
1
2023 - 07 - 12
1
2023 - 07 - 10
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 20
1
2023 - 06 - 16
2
2023 - 06 - 01
1
2023 - 05 - 31
1
2023 - 05 - 15
1
2023 - 05 - 10
1
2023 - 05 - 04
1
2023 - 04 - 21
1
2023 - 01 - 24
1
2022 - 12 - 13
1
2022 - 11 - 21
1
2022 - 10 - 17
1
2022 - 09 - 27
1
2022 - 09 - 13
1
2022 - 08 - 22
1
2022 - 06 - 21
1
2022 - 05 - 05
2
2022 - 05 - 02
1
2022 - 04 - 28
1
2022 - 04 - 06
1
2022 - 03 - 14
1
2022 - 02 - 07
1
2022 - 01 - 20
1
2022 - 01 - 19
1
2022 - 01 - 06
2
2022 - 01 - 05
1
2021 - 12 - 16
2
2021 - 12 - 07
1
2021 - 11 - 25
1
2021 - 11 - 02
1
2021 - 10 - 18
1
2021 - 10 - 12
1
2021 - 10 - 11
1
2021 - 09 - 20
1
2021 - 09 - 13
1
2021 - 06 - 23
1
2021 - 05 - 12
1
2021 - 05 - 07
1
2021 - 04 - 14
1
2021 - 04 - 01
1
2021 - 02 - 12
1
Sector
Communications
4
Consumer services
1
Electronic technology
4
Energy minerals
1
Finance
4
Health services
4
Health technology
27
Manufacturing
6
Mining, quarrying, and oil and gas extraction
1
N/a
9
Process industries
2
Producer manufacturing
2
Technology services
4
Transportation
1
Utilities
1
Tags
Acquired
1
Acquisition
3
Agreement
1
Als
1
Alternative
1
Antibody
1
Application
2
Approval
31
Approved
8
Arm
1
Authorization
1
Aviptadil
3
Avt02
1
Bacteria
1
Biocapital
1
Biopharma
1
Biosimilar
2
Breast cancer
1
Business
1
Camzyos
1
Cancer
3
Candidate
1
Cannabis
1
Ce mark
1
Children
1
China
4
Chinese
1
City
1
Clinical-trials-phase-iii
1
Collaboration
1
Commercialization
1
Communication
2
Communications
2
Covid
4
Covid-19
5
Deadline
1
Diabetes
1
Disease
3
Distribution
2
Drug
2
Dry eye
1
Elfabrio
1
Emergency use authorization
1
Energy
1
Europe
5
Fda
7
Global
5
Japan
2
Market
4
Media
2
Merge
2
N/a
44
Offering
2
Positive
2
Potential
2
Regulatory
9
Report
4
Risk
2
System
2
Treatment
12
Entities
Abbott laboratories
1
Abiomed, inc.
1
Aercap holdings n.v.
1
Allied corp.
1
Alvotech lux holdings s.a.s.
3
Amarin corporation plc
1
Amerant bancorp inc.
1
Argenx se
1
Arrival
1
Astrazeneca plc
1
Atlis motor vehicles inc
1
Atricure, inc.
1
Aurora cannabis inc.
1
Ballard power systems, inc.
1
Beigene, ltd.
2
Borgwarner inc.
1
Boston scientific corporation
1
Bristol-myers squibb company
1
Broadcom inc.
1
Camden property trust
1
Canoo inc - class a
1
Cara therapeutics, inc.
1
Cardiovascular systems, inc.
1
Chipmos technologies inc.
1
Daqo new energy corp.
1
Davita inc.
1
Denso corp
1
Edwards lifesciences corporation
1
Fresenius medical care ag & co. kgaa
1
General electric company
1
Genmab a/s
1
Gilead sciences, inc.
2
Golden ocean group limited
1
Gsi technology, inc.
1
Guardant health, inc.
1
Hennessy capital investment corp. vi
1
High tide inc.
1
I-80 gold corp
1
I-mab
1
Incyte corporation
1
Jtekt corp
1
Kamada ltd.
3
Kenon holdings ltd.
1
Kt corporation
1
Liquidia technologies, inc.
2
Livanova plc
1
Medtronic plc
1
Mirum pharmaceuticals, inc.
1
Neovasc inc.
1
Novartis ag
2
Nrx pharmaceuticals inc
2
Orange
1
Oyster point pharma, inc.
1
Paratek pharmaceuticals, inc.
1
Partner communications company ltd.
2
Predictmedix inc.
1
Protalix biotherapeutics, inc.
1
Qiagen n.v.
1
Relief therapeutics holding sa
3
Teva pharmaceutical industries ltd
3
Symbols
ABMD
1
ABT
1
ACB
1
AER
1
ALID
1
ALVO
3
AMRN
1
AMTB
1
AMV
1
ARGX
1
ARVL
1
ATRC
1
AVGO
1
AZN
1
BGNE
2
BLDP
1
BMY
1
BSX
1
BWA
1
CARA
1
CPT
1
CSII
1
DNZOF
1
DNZOY
1
DQ
1
DVA
1
EW
1
FMCQF
1
FNCTF
1
GE
1
GH
1
GILD
2
GMAB
1
GNMSF
1
GOEV
1
GOGL
1
GSIT
1
HCVI
1
HITI
1
HYSR
1
IAUX
1
IMAB
1
IMOS
1
INCY
1
JTEKY
1
KEN
1
KMDA
3
KT
1
LIVN
1
LQDA
2
MDT
1
MIRM
1
NRXP
2
NVCN
1
NVS
2
NVSEF
2
PTNR
2
RLFTF
3
RLFTY
3
TEVJF
3
Exchanges
Amex
1
Nasdaq
50
Nyse
17
Crawled Date
2024 - 04 - 19
1
2024 - 04 - 01
1
2024 - 03 - 27
1
2024 - 03 - 18
1
2024 - 02 - 06
1
2024 - 01 - 08
1
2023 - 10 - 02
1
2023 - 09 - 25
1
2023 - 09 - 20
1
2023 - 09 - 15
2
2023 - 07 - 27
1
2023 - 07 - 12
1
2023 - 07 - 10
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 20
1
2023 - 06 - 16
2
2023 - 06 - 01
1
2023 - 05 - 31
1
2023 - 05 - 15
1
2023 - 05 - 10
1
2023 - 05 - 04
1
2023 - 04 - 21
1
2023 - 01 - 24
1
2022 - 12 - 13
1
2022 - 11 - 21
1
2022 - 10 - 17
1
2022 - 09 - 27
1
2022 - 09 - 13
1
2022 - 08 - 22
1
2022 - 06 - 21
1
2022 - 05 - 05
2
2022 - 05 - 02
1
2022 - 04 - 28
1
2022 - 04 - 06
1
2022 - 03 - 14
1
2022 - 02 - 07
1
2022 - 01 - 20
1
2022 - 01 - 19
1
2022 - 01 - 06
3
2021 - 12 - 16
2
2021 - 12 - 07
1
2021 - 11 - 25
1
2021 - 11 - 02
1
2021 - 10 - 18
1
2021 - 10 - 12
1
2021 - 10 - 11
1
2021 - 09 - 20
1
2021 - 09 - 13
1
2021 - 06 - 23
1
2021 - 05 - 12
1
2021 - 05 - 07
1
2021 - 04 - 14
1
2021 - 04 - 01
1
2021 - 02 - 12
1
Crawled Time
00:00
100
00:01
3
00:12
2
00:20
17
01:00
63
02:00
23
03:00
20
04:00
14
04:20
15
05:00
19
06:00
49
07:00
51
07:01
2
08:00
45
08:20
6
09:00
65
10:00
61
10:41
3
11:00
162
12:00
370
12:01
3
12:02
2
12:03
4
12:05
2
12:07
5
12:15
31
12:20
83
12:30
70
13:00
334
13:01
4
13:02
2
13:03
10
13:05
2
13:15
18
13:20
73
13:30
86
13:47
5
14:00
272
14:01
4
14:15
8
14:20
43
14:30
58
15:00
163
15:15
14
15:20
32
15:30
47
16:00
98
16:20
6
17:00
143
18:00
129
19:00
132
20:00
160
21:00
285
21:03
3
21:06
3
22:00
253
22:01
7
22:03
3
22:07
3
23:00
176
Source
hightideinc.com
1
spacfeed.com
2
www.biospace.com
17
www.globenewswire.com
20
www.predictmedix.com
1
www.prnewswire.com
20
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
approved
crawled time :
10:00
save search
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published:
2024-04-19
(Crawled : 10:00)
- globenewswire.com
ALVO
|
$13.65
1.87%
120K
|
n/a
|
3.88%
|
O:
1.16%
H:
7.28%
C:
1.3%
KMDA
|
$5.1
3.2K
|
Health Technology
|
1.76%
|
O:
1.76%
H:
0.0%
C:
0.0%
humira
biosimilar
approved
for
agreement
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
Published:
2024-04-01
(Crawled : 10:00)
- globenewswire.com
LQDA
S
|
$12.685
-2.05%
240K
|
Health Technology
|
-13.95%
|
O:
2.99%
H:
0.06%
C:
-3.74%
fda
approval
favorable
update
potential
UP Fintech Holding Limited’s Hong Kong Subsidiary Receives SFC Approval on Type 9 License to Provide Asset Management Services
Published:
2024-03-27
(Crawled : 10:00)
- globenewswire.com
TIGR
|
$3.36
-0.59%
490K
|
Finance
|
-0.88%
|
O:
-0.29%
H:
2.21%
C:
0.88%
management
services
license
approval
Canoo’s Oklahoma City Manufacturing Facility Approved as Foreign Trade Zone
Published:
2024-03-18
(Crawled : 10:00)
- globenewswire.com
GOEV
4
|
$3.16
-0.32%
910K
|
|
63.4%
|
O:
20.62%
H:
65.81%
C:
23.93%
approved
city
zone
Yiren Digital's Insurance Arm Secures Spot on FESCO's Approved Supplier List
Published:
2024-02-06
(Crawled : 10:00)
- prnewswire.com
YRD
|
$5.05
0.6%
22K
|
Technology Services
|
14.09%
|
O:
1.14%
H:
8.54%
C:
8.54%
arm
approved
insurance
FDA approves Ligand's molluscum contagiosum treatment – Pharmaceutical Technology
Published:
2024-01-08
(Crawled : 10:00)
- spacfeed.com
CPT
4
|
$98.98
0.39%
140K
|
Finance
|
0.42%
|
O:
-0.46%
H:
1.63%
C:
1.54%
molluscum
fda
treatment
technology
Hennessy Capital Investment Corp. VI Announces Stockholder Approval of Extension of Deadline to Complete Business Combination to January 10, 2024
Published:
2023-10-02
(Crawled : 10:00)
- globenewswire.com
HCVI
|
$10.49
520
|
n/a
|
1.55%
|
O:
0.1%
H:
0.1%
C:
0.0%
business
approval
deadline
extension
EPKINLYTM (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare as the First Bispecific Antibody to Treat Adults Patients with Certain Types of Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Published:
2023-09-25
(Crawled : 10:00)
- globenewswire.com
GNMSF
|
News
|
$290.34
340
|
Health Technology
|
-20.51%
|
O:
-2.37%
H:
2.64%
C:
2.61%
GMAB
|
News
|
$28.33
-0.81%
98K
|
Health Technology
|
-20.84%
|
O:
-0.14%
H:
0.86%
C:
0.62%
japan
antibody
approved
treat
Global Claudin 18.2-Targeted Immunotherapy Landscape Analysis Report 2023: Potential Approvals and Market Launches Expected During the Course of 2024
Published:
2023-09-20
(Crawled : 10:00)
- prnewswire.com
IMAB
|
$1.81
0.56%
17K
|
Health Technology
|
34.33%
|
O:
0.0%
H:
1.49%
C:
-6.72%
report
expected
global
immunotherapy
potential
market
trivago N.V. Announces an Extraordinary General Meeting of Shareholders to Approve One-time Extraordinary Dividend
Published:
2023-09-15
(Crawled : 10:00)
- globenewswire.com
TRVG
|
News
|
$2.59
5K
|
Technology Services
|
-52.48%
|
O:
3.67%
H:
3.98%
C:
-1.77%
meeting
Novartis shareholders approve the proposed 100% Spin-off of Sandoz
Published:
2023-09-15
(Crawled : 10:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
52K
|
Health Technology
|
13.27%
|
O:
0.79%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.515
0.24%
820K
|
Health Technology
|
-2.92%
|
O:
1.51%
H:
0.26%
C:
-0.72%
novartis
Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA™ (treprostinil) Inhalation Powder
Published:
2023-07-27
(Crawled : 10:00)
- globenewswire.com
FNCTF
|
News
|
$11.16
130
|
Communications
|
-6.06%
|
O:
1.23%
H:
0.0%
C:
0.0%
UTHR
|
$240.275
2.48%
140K
|
Health Technology
|
-3.45%
|
O:
0.36%
H:
0.0%
C:
-0.39%
LQDA
S
|
$12.685
-2.05%
240K
|
Health Technology
|
83.56%
|
O:
1.35%
H:
2.87%
C:
2.24%
approved
European Commission Approves Broadcom's Acquisition of VMware
Published:
2023-07-12
(Crawled : 10:00)
- prnewswire.com
VMW
|
$142.48
-4.96%
0.37%
0
|
Technology Services
|
-5.44%
|
O:
1.87%
H:
1.14%
C:
0.89%
AVGO
|
News
|
$1249.005
-0.02%
840K
|
Electronic Technology
|
41.62%
|
O:
0.79%
H:
0.97%
C:
0.11%
acquisition
Vermilion Energy Inc. Announces TSX Approval for Renewal of Normal Course Issuer Bid
Published:
2023-07-10
(Crawled : 10:00)
- prnewswire.com
VET
|
$11.86
-1.17%
180K
|
Energy Minerals
|
-7.05%
|
O:
0.31%
H:
3.32%
C:
1.85%
energy
approval
ThinkMarkets SPAC Acquisition Partner Gets Shareholders’ Approvals – Finance Magnates
Published:
2023-06-30
(Crawled : 10:00)
- spacfeed.com
USCT
|
$11.24
100
|
n/a
|
Email alert
Add to watchlist
spac
acquisition
i-80 Gold Receives Approval to Begin Drilling in the Hilltop Corridor at Ruby Hill
Published:
2023-06-27
(Crawled : 10:00)
- prnewswire.com
IAUX
|
$1.22
-0.81%
860K
|
Mining, Quarrying, and Oil and ...
|
-41.15%
|
O:
0.0%
H:
0.96%
C:
-0.48%
approval
SunHydrogen Announces Approval of $3.1 Million in Funding for Project NanoPEC, a Scale-Up Cooperation with Partners at the Cutting Edge of German Industry and Science
Published:
2023-06-20
(Crawled : 10:00)
- globenewswire.com
HYSR
|
$0.0134
4.7M
|
Manufacturing
|
-45.95%
|
O:
2.7%
H:
3.68%
C:
-6.84%
approval
funding
Reata Pharmaceuticals Announces FDA Filing Acceptance of SKYCLARYS® (Omaveloxlone) NDA Prior Approval Supplement
Published:
2023-06-16
(Crawled : 10:00)
- biospace.com/
RETA
|
$172.36
0.02%
0.03%
0
|
Health Technology
|
84.13%
|
O:
3.5%
H:
0.81%
C:
-3.62%
skyclarys
fda
approval
pharmaceuticals
U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS® (mavacamten) Label
Published:
2023-06-16
(Crawled : 10:00)
- biospace.com/
BMY
|
$48.76
-0.47%
3.9M
|
Health Technology
|
-24.25%
|
O:
0.32%
H:
2.1%
C:
1.97%
camzyos
drug
label
food
positive
study
Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China
Published:
2023-06-01
(Crawled : 10:00)
- globenewswire.com
AMRN
|
News
|
$0.8685
-1.68%
290K
|
Health Technology
|
-25.21%
|
O:
3.42%
H:
4.96%
C:
0.0%
vascepa
approval
china
← Previous
1
2
3
4
Next →
Gainers vs Losers
55%
45%
Top 10 Gainers
CSSE
4
|
$0.3499
129.74%
150M
|
Consumer Services
CZOO
|
$11.04
121.24%
9.6M
|
BOF
|
$2.05
75.21%
78M
|
AMST
|
$3.2
60.0%
63M
|
Technology Services
WIMI
|
$1.05
44.75%
13M
|
Technology Services
LICN
|
$0.7885
40.8%
11M
|
TROO
|
$1.51
38.53%
5.6M
|
Manufacturing
MULN
|
News
|
$3.7
35.53%
6.4M
|
Information
RILY
|
$27.91
28.5%
8.9M
|
Finance
WHLM
|
$6.43
26.58%
580K
|
Commercial Services
Your saved searches
Save your searches and get alerts when important news are released.